Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age
ContributorsBaud, Olivier; Trousson, Clémence; Biran, Valérie; Leroy, Emilie; Mohamed, Damir; Alberti, Corinne
Published inJAMA (Journal of the American Medical Association), vol. 317, no. 13, p. 1329-1337
Publication date2017
Abstract
Keywords
- Anti-Inflammatory Agents/adverse effects/therapeutic use
- Bronchopulmonary Dysplasia/prevention & control
- Cerebral Palsy
- Child Development
- Child, Preschool
- Female
- Follow-Up Studies
- Gestational Age
- Humans
- Hydrocortisone/adverse effects/therapeutic use
- Infant
- Infant, Extremely Premature
- Infant, Newborn
- Male
- Nervous System Diseases
Affiliation entities Not a UNIGE publication
Citation (ISO format)
BAUD, Olivier et al. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age. In: JAMA (Journal of the American Medical Association), 2017, vol. 317, n° 13, p. 1329–1337. doi: 10.1001/jama.2017.2692
Main files (1)
Article (Published version)
Identifiers
- PID : unige:104567
- DOI : 10.1001/jama.2017.2692
- PMID : 28384828
Journal ISSN0098-7484
